Skip Navigation



JAC Advance Access published online on September 29, 2005

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki350
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/5/957    most recent
dki350v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Liao, M.
Right arrow Articles by Dillon, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, M.
Right arrow Articles by Dillon, J. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received March 29, 2005
Revised August 16, 2005
Accepted September 8, 2005

Brief report

Cationic peptide of the male reproductive tract, HE2{alpha}, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis

M. Liao 1, P. S. Ruddock 2, A. S. Rizvi 3, S. H. Hall 4, F. S. French 4, and J. R. Dillon 5*

1 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, ON, Canada, K1H 8M5; Centre for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, ON, Canada, K1H 8M5; Present address. Room A233, 120 Veterinary Road, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E3
2 Department of Biology, University of Ottawa, ON, Canada, K1H 8M5
3 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, ON, Canada, K1H 8M5
4 Laboratories for Reproductive Biology, University of North Carolina at Chapel Hill, Campus Box 7500, Chapel Hill, NC 27599, USA
5 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, ON, Canada, K1H 8M5; Centre for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, ON, Canada, K1H 8M5; Department of Biology, University of Ottawa, ON, Canada, K1H 8M5

* To whom correspondence should be addressed.
J. R. Dillon, E-mail: j.dillon{at}usask.ca


   Abstract

Objectives: To analyse the in vitro antimicrobial effects of synthetic HE2{alpha} peptide against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.

Methods: The HE2{alpha} peptide was synthesized based on the C-terminal sequence of the HE2{alpha} protein. The bacterial strains tested included two antibiotic-susceptible strains of N. gonorrhoeae and four antibiotic-resistant clinical isolates, as well as S. aureus ATCC 29213 and E. faecalis ATCC 29212. Susceptibility determinations were carried out either in 0.7% casamino acids for N. gonorrhoeae isolates or in 10 mM phosphate buffer for S. aureus and E. faecalis strains. Antibacterial effects were measured in a dose- and time-dependent manner. After exposure to the peptide in solution, the number of viable cells was determined by counting colony forming units (cfu).

Results: The HE2{alpha} peptide exhibited time- and dose-dependent antibacterial effects on all N. gonorrhoeae isolates tested. S. aureus and E. faecalis strains were also susceptible to the peptide. All strains tested were susceptible to the peptide at high concentrations (50 or 100 mg/L) and some strains were susceptible to a peptide concentration of 25 mg/L.

Conclusions: The peptide HE2{alpha}, which is derived from the male urogenital tract, exhibits antibacterial activity against both Gram-positive and Gram-negative pathogens in vitro. The peptide is active against both antibiotic-susceptible and -resistant N. gonorrhoeae isolates. Further investigation of the antimicrobial properties of the peptide is warranted.

Keywords: susceptibility tests; antimicrobial peptides; sexually transmitted diseases; pathogenic bacteria.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
Y. Rukayadi, K. Lee, S. Han, D. Yong, and J.-K. Hwang
In Vitro Activities of Panduratin A against Clinical Staphylococcus Strains
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4529 - 4532.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. W. Avellar, L. Honda, K. G. Hamil, Y. Radhakrishnan, S. Yenugu, G. Grossman, P. Petrusz, F. S. French, and S. H. Hall
Novel Aspects of the Sperm-Associated Antigen 11 (SPAG11) Gene Organization and Expression in Cattle (Bos taurus)
Biol Reprod, June 1, 2007; 76(6): 1103 - 1116.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.